From 4 June 2024, the IRIS platform will provide a secure online environment for applicants to submit and manage their paediatric medicines applications and related documents. The previous submission process only applies for ongoing applications submitted before 4 June. With IRIS, applicants can check the status of their applications and get automatic updates from any device. IRIS simplifies interaction with EMA, improves data quality, transparency and efficiency in the paediatric application process.
Excerpt from the official page. The original is authoritative.